News for 'Sun Pharmaceutical Industries'

What Putin hopes to achieve on his India visit

What Putin hopes to achieve on his India visit

Rediff.com3 Dec 2025

Russian President Vladimir Putin's visit to India this week aims to secure energy supplies, stabilise defence deliveries and ensure bilateral trade continues smoothly despite strong Western sanctions, GTRI said on Tuesday.

Union Budget 2026: Sitharaman tries to cover all bases, leaves out markets

Union Budget 2026: Sitharaman tries to cover all bases, leaves out markets

Rediff.com1 Feb 2026

Budget 2026 sticks to fiscal discipline, shuns populist measures despite five key state elections coming up, but ends up rattling stock markets with a higher transaction tax on derivatives trading.

What Weapons Will Putin Sell India On Rare State Visit?

What Weapons Will Putin Sell India On Rare State Visit?

Rediff.com29 Nov 2025

On the table are additional batches of S-400 surface-to-air missile systems from Russia, which India used with immense success during Operation Sindoor. India could buy at least two squadrons of Su-57 fighter jets plus joint production of S-500 air defence systems.

Will Tata Sons Get RBI Relief?

Will Tata Sons Get RBI Relief?

Rediff.com24 Oct 2025

Tata Sons, now debt-free, has asked the RBI to drop its 'upper-layer NBFC' tag and allow it to stay private.

Factors that will guide the markets this week

Factors that will guide the markets this week

Rediff.com18 May 2025

Stock markets will be mainly driven by quarterly earnings by corporates, foreign fund flows and global trends this week, analysts said.

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Rediff.com14 May 2025

A fresh US executive order (EO) which seeks to bring down prices of prescription drugs in the country by up to 90 per cent -- on par with other developed nations -- will affect innovator companies, while sparing the Indian generic drug makers in the short term. US President Donald Trump signed the EO on Monday, directing the US Trade Representative and the Secretary of Commerce to act against foreign countries that "purposefully and unfairly undercut market prices", driving price hikes in the US.

Sensex jumps 595 points on strong global cues

Sensex jumps 595 points on strong global cues

Rediff.com12 Nov 2025

From the Sensex pack, Asian Paints, Tech Mahindra, Tata Consultancy Services, Bajaj Finserv, Adani Ports, HCL Technologies, Bharti Airtel, Infosys, Trent, Reliance Industries, UltraTech Cement, Sun Pharmaceuticals, Eternal, Titan and Bajaj Finance were the gainers. On the other hand, Tata Steel, Tata Motors Passenger Vehicles, Tata Motors Commercial Vehicles, Bharat Electronics, Kotak Mahindra Bank and PowerGrid were the laggards.

USFDA's new draft biosimilar rules to benefit Indian biotech cos

USFDA's new draft biosimilar rules to benefit Indian biotech cos

Rediff.com9 Nov 2025

The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.

GST cut on drugs, medical devices to help patients

GST cut on drugs, medical devices to help patients

Rediff.com4 Sep 2025

The government's move to cut GST on medicines and medical devices while exempting lifesaving drugs from the levy is a bold step that will bring direct relief to patients and families while significantly reducing financial strain on them, pharmaceuticals and healthcare industry players said on Thursday.

Mankind taps OpenAI to institutionalise AI in ops

Mankind taps OpenAI to institutionalise AI in ops

Rediff.com18 Sep 2025

Delhi-based pharma major Mankind Pharma on Wednesday announced a collaboration with OpenAI to institutionalise artificial intelligence (AI) across its value chain, making it one of the first few Indian pharmaceutical companies to fully integrate advanced AI into its core operations.

Where The Deadly Cough Syrup Was Made

Where The Deadly Cough Syrup Was Made

Rediff.com18 Oct 2025

Sandwiched between a Hero MotoCorp showroom and a shop that hires out cooking utensils is a small, dingy building that's been locked up. The non-descript two-room building is a manufacturing unit of Sresan Pharmaceuticals, the pharma company made its Coldriff cough syrup that has allegedly killed 25 children in Madhya Pradesh.

Indian pharma industry 3rd largest globally:Survey

Indian pharma industry 3rd largest globally:Survey

Rediff.com25 Feb 2010

The growth of the Indian pharmaceutical industry has been fuelled by exports, which increased 25 per cent in 2008-09. "Exports of pharmaceuticals have consistently outstripped imports," the Survey said.

'India Should Not Rush To Celebrate Trump's Trade Announcement'

'India Should Not Rush To Celebrate Trump's Trade Announcement'

Rediff.com3 Feb 2026

'Trump says India will buy over $500 billion of US goods.' 'At present, India's annual imports of goods and energy from the US are under $50 billion.' 'Reaching $500 billion would likely require more than 20 years, suggesting the figure refers to a long-term aspiration rather than a near-term commitment.'

Cough syrup deaths: No state follows pharma safety norms

Cough syrup deaths: No state follows pharma safety norms

Rediff.com10 Oct 2025

The Central Drugs Standard Control Organisation (CDSCO) will conduct testing, inspection and auditing of cough syrup manufacturers.

How India's pharma cos plan to tackle steep US tariffs

How India's pharma cos plan to tackle steep US tariffs

Rediff.com10 Sep 2025

As the potential threat of a steep 200 per cent tariff on pharmaceutical imports hangs in the air, analysts and industry insiders feel that focus on exports to non-US regions as well as domestic market will increase as a long-term trend. US President Donald Trump told CNBC's Squawk Box in the first week of August that planned tariffs on import of pharmaceutical products to the US could eventually reach up to 250 per cent.

Gujarat pharma industry seeks sops

Gujarat pharma industry seeks sops

Rediff.com7 Jul 2003

'Indian Youth Can Expect Career Growth In Russia'

'Indian Youth Can Expect Career Growth In Russia'

Rediff.com4 Dec 2025

'Don't look at Russia only as a place to earn quickly and then leave.' 'Try to build experience in serious companies, skills and certifications that will serve you anywhere in the world.'

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Rediff.com31 Jul 2025

India's pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25 per cent tariff rate on India on a social networking platform without divulging the finer details.

Govt Targets 100 Products For Aatmanirbhar Push

Govt Targets 100 Products For Aatmanirbhar Push

Rediff.com16 Sep 2025

'Our endeavour will be that we identify these products, put them in the public domain so that the manufacturers can look at them and give a boost to Make in India.'

Cough syrup deaths: IMA slams doctor's arrest

Cough syrup deaths: IMA slams doctor's arrest

Rediff.com7 Oct 2025

The Indian Medical Association (IMA) has defended a doctor arrested in connection with cough syrup deaths in Madhya Pradesh, attributing the incident to failures in the drugs regulatory system.

Sun Pharma stock up 2.15% as US court clears alopecia drug launch

Sun Pharma stock up 2.15% as US court clears alopecia drug launch

Rediff.com12 Apr 2025

Sun Pharmaceutical Industries stock ended 2.15 per cent higher on Friday after zooming by almost 5 per cent in the morning trade on the back of an announcement that a court ruling has cleared the deck for the India's largest pharmaceutical company to launch its alopecia drug Leqselvi in the United States.

Kremlin Didn't Know About Modi Gesture

Kremlin Didn't Know About Modi Gesture

Rediff.com5 Dec 2025

The Russians have termed Putin's visit to India, his first to this country since the outbreak of the Russia-Ukraine war, as 'Druzhba Dosti', which means 'friendship' in Russian and Hindi respectively.

Factors that will drive the markets this week

Factors that will drive the markets this week

Rediff.com28 Sep 2025

Stock markets will be driven by RBI's interest rate decision, tariff-related developments, global trends and trading activity of foreign investors in this holiday-shortened week, analysts said.

From 1905 cry to Modi's 'Vocal for Local': NCERT's new Swadeshi lessons

From 1905 cry to Modi's 'Vocal for Local': NCERT's new Swadeshi lessons

Rediff.com3 Oct 2025

Two modules published by the NCERT, Swadeshi: Vocal for Local (for middle stage) and Swadeshi: For a Self-Reliant India (for secondary stage), carry excerpts from the prime minister's Independence Day address in which he stressed that self-reliance would drive India's journey towards a Viksit Bharat.

Govt to Monitor Non-Essential Drug Prices

Govt to Monitor Non-Essential Drug Prices

Rediff.com28 Jul 2025

The National Pharmaceutical Pricing Authority will monitor how companies are increasing prices of non-scheduled drugs.

Cough syrup deaths: Many states ban Coldrif; MP suspends officials

Cough syrup deaths: Many states ban Coldrif; MP suspends officials

Rediff.com7 Oct 2025

A special investigation team (SIT) has been formed in Madhya Pradesh to investigate the deaths of 14 children in Chhindwara, suspected to be linked to a toxic cough syrup. The investigation includes arrests, exhumations, and a ban on the implicated cough syrup.

India relationship...: What Rubio said after Jaishankar meet

India relationship...: What Rubio said after Jaishankar meet

Rediff.com23 Sep 2025

Rubio voiced "appreciation" for New Delhi's continued engagement on bilateral issues, including trade, defence and energy.

Modi, Putin unveil 2030 roadmap amid US pressure

Modi, Putin unveil 2030 roadmap amid US pressure

Rediff.com5 Dec 2025

India and Russia have solidified a five-year plan to enhance their economic and trade partnership, while also addressing the ongoing conflict in Ukraine and the threat of terrorism.

Want To Invest In Manufacturing Funds?

Want To Invest In Manufacturing Funds?

Rediff.com3 Nov 2025

'They are a poor fit for anyone with near-term goals, low volatility tolerance, or a need for steady income or liquidity.' 'First-time investors should typically avoid them.'

Credit quality of companies likely to remain stable in H2

Credit quality of companies likely to remain stable in H2

Rediff.com8 Oct 2025

Credit quality of Indian corporate is expected to be stable in the second half of the current financial year (H2FY26), supported by easing monetary cycle, and declining inflation, coupled with income-tax relief and rationalisation of the goods and service tax (GST) rates, among others.

Who Are India's Newest Billionaires?

Who Are India's Newest Billionaires?

Rediff.com11 Oct 2024

The collective wealth of the 100 richest went past $1 trillion for the first time.

15 killed, 34 hurt in explosion at Telangana pharma plant

15 killed, 34 hurt in explosion at Telangana pharma plant

Rediff.com1 Jul 2025

At least 12 people died and 34 persons were injured in a pharma plant explosion in Sangareddy district of Telangana on Monday, State Minister Damodara Raja Narasimha said.

'Trump Wants Big Pie Of India's Economy'

'Trump Wants Big Pie Of India's Economy'

Rediff.com4 Aug 2025

'India did not surrender. That was why he wanted to pressurise India by this 25% tariffs.'

Sensex drops 308 pts; RIL, HDFC Bank major drags

Sensex drops 308 pts; RIL, HDFC Bank major drags

Rediff.com5 Aug 2025

Among Sensex shares, Adani Ports, Reliance Industries, Infosys, ICICI Bank, Eternal, BEL, HDFC Bank, Power Grid, ITC and Sun Pharmaceutical were the major laggards. However, Titan, Maruti, Trent, Bharti Airtel, Bajaj Finance, Tech Mahindra, State Bank of India, L&T, HCL Technologies and NTPC were among the gainers.

India's Space Manufacturing Boom

India's Space Manufacturing Boom

Rediff.com15 Aug 2025

The $1.2 billion in-space manufacturing market is expected to grow and be worth more than $20 billion by 2033.

Sensex tumbles 849 points; slips below 81K

Sensex tumbles 849 points; slips below 81K

Rediff.com26 Aug 2025

Among Sensex shares, Sun Pharmaceutical, Tata Steel, Trent, Bajaj Finance, Mahindra & Mahindra, Bajaj Finserv, Reliance Industries, Axis Bank, Tech Mahindra, Adani Ports, Titan, BEL, and Larsen & Toubro were the major laggards. However, Hindustan Unilever, Maruti Suzuki India, ITC, Tata Consultancy Services and UltraTech Cement were the gainers.

Banks can now fund India Inc's M&A drive

Banks can now fund India Inc's M&A drive

Rediff.com2 Oct 2025

The Reserve Bank of India (RBI) on Wednesday met the long-standing demand of banks by allowing them to finance acquisitions by Indian companies, a move that also expands banks' capital market lending in the country.

'Trump Respects India's Friendship'

'Trump Respects India's Friendship'

Rediff.com7 Mar 2025

'The cooperation in technology is one of the most important aspects of the visit.' 'It will have a long-lasting impact because it will shift the entire paradigm in the context of artificial intelligence and emerging technologies.'

US Tariffs Coming Tomorrow!

US Tariffs Coming Tomorrow!

Rediff.com26 Aug 2025

From 12:01 am eastern daylight time on August 27, 2025, higher tariffs will apply to all products of India that are either entered for consumption in the United States or withdrawn from warehouses for consumption.

Takeover concerns: Pharma industry seeks govt help

Takeover concerns: Pharma industry seeks govt help

Rediff.com6 Nov 2009

Concerned over the recent takeover of some firms by MNCs, the domestic pharmaceutical industry has asked the government to protect and promote it by making available funds for research and development.